Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study of p62/SQSTM1 as a Malignant Transformation Marker for Oral Potentially Malignant Disorders and a Prognostic Marker for Oral Squamous Cell Carcinoma

NCT01946230 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT01946230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01946230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study of p62/SQSTM1 as a Malignant Transformation Marker for Oral Potentially Malignant Disorders and a Prognostic Marker for Oral Squamous Cell Carcinoma
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2014
Completion date
Not reported
Enrollment
2,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malignant disorder, oral cancer, oral potentially malignant disorder, p62/sqstm1